Innoveren Scientific, Inc. is a hybrid-biopharmaceutical company. It engages in the business of acquiring and developing early-stage companies and technologies in the areas of therapeutics, medical devices, and diagnostics. The company was founded by Scott M. W. Haufe and Steven Gorlin on July 30, 2013 and is headquartered in Cincinnati, OH.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of H-CYTE Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. H-CYTE Inc market cap is $600.00.
What is the 52-week high for H-CYTE Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. H-CYTE Inc 52 week high is $0.005 as of September 06, 2025.
What is the 52-week low for H-CYTE Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. H-CYTE Inc 52 week low is $0.00 as of September 06, 2025.
What is H-CYTE Inc stock price today?
H-CYTE Inc stock price today is $0.075.
What was H-CYTE Inc stock price yesterday?
H-CYTE Inc stock price yesterday was $0.09.
What is the 50-day moving average of H-CYTE Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. H-CYTE Inc 50-day moving average is $0.0002.